BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 16322467)

  • 1. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
    Kertesz N; Krasnoperov V; Reddy R; Leshanski L; Kumar SR; Zozulya S; Gill PS
    Blood; 2006 Mar; 107(6):2330-8. PubMed ID: 16322467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro.
    He S; Kumar SR; Zhou P; Krasnoperov V; Ryan SJ; Gill PS; Hinton DR
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):543-52. PubMed ID: 19696168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble EphB4 regulates choroidal endothelial cell function and inhibits laser-induced choroidal neovascularization.
    He S; Ding Y; Zhou J; Krasnoperov V; Zozulya S; Kumar SR; Ryan SJ; Gill PS; Hinton DR
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4772-9. PubMed ID: 16303978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of tumor growth and angiogenesis by soluble EphB4.
    Martiny-Baron G; Korff T; Schaffner F; Esser N; Eggstein S; Marmé D; Augustin HG
    Neoplasia; 2004; 6(3):248-57. PubMed ID: 15153337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T; Korff T; Kilian A; Dandekar G; Augustin HG
    J Cell Sci; 2003 Jun; 116(Pt 12):2461-70. PubMed ID: 12734395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
    Djokovic D; Trindade A; Gigante J; Badenes M; Silva L; Liu R; Li X; Gong M; Krasnoperov V; Gill PS; Duarte A
    BMC Cancer; 2010 Nov; 10():641. PubMed ID: 21092311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of Ephs, Ephrins, and growth factors in Kaposi sarcoma and implications of EphrinB2 blockade.
    Scehnet JS; Ley EJ; Krasnoperov V; Liu R; Manchanda PK; Sjoberg E; Kostecke AP; Gupta S; Kumar SR; Gill PS
    Blood; 2009 Jan; 113(1):254-63. PubMed ID: 18836096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EphrinB2/EphB4 inhibition in the osteoblast lineage modifies the anabolic response to parathyroid hormone.
    Takyar FM; Tonna S; Ho PW; Crimeen-Irwin B; Baker EK; Martin TJ; Sims NA
    J Bone Miner Res; 2013 Apr; 28(4):912-25. PubMed ID: 23165727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
    Du E; Li X; He S; Li X; He S
    Mol Biol Rep; 2020 Jun; 47(6):4681-4690. PubMed ID: 32488576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
    Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphB4 promotes site-specific metastatic tumor cell dissemination by interacting with endothelial cell-expressed ephrinB2.
    Héroult M; Schaffner F; Pfaff D; Prahst C; Kirmse R; Kutschera S; Riedel M; Ludwig T; Vajkoczy P; Graeser R; Augustin HG
    Mol Cancer Res; 2010 Oct; 8(10):1297-309. PubMed ID: 21047731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.
    Sturz A; Bader B; Thierauch KH; Glienke J
    Biochem Biophys Res Commun; 2004 Jan; 313(1):80-8. PubMed ID: 14672701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy.
    Ehlken C; Martin G; Lange C; Gogaki EG; Fiedler U; Schaffner F; Hansen LL; Augustin HG; Agostini HT
    Acta Ophthalmol; 2011 Feb; 89(1):82-90. PubMed ID: 19764912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Communication between ephrinB2 and EphB4 within the osteoblast lineage.
    Martin TJ; Allan EH; Ho PW; Gooi JH; Quinn JM; Gillespie MT; Krasnoperov V; Sims NA
    Adv Exp Med Biol; 2010; 658():51-60. PubMed ID: 19950015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
    Groppa E; Brkic S; Uccelli A; Wirth G; Korpisalo-Pirinen P; Filippova M; Dasen B; Sacchi V; Muraro MG; Trani M; Reginato S; Gianni-Barrera R; Ylä-Herttuala S; Banfi A
    EMBO Rep; 2018 May; 19(5):. PubMed ID: 29643120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syndecan-1 up-regulated by ephrinB2/EphB4 plays dual roles in inflammatory angiogenesis.
    Yuan K; Hong TM; Chen JJ; Tsai WH; Lin MT
    Blood; 2004 Aug; 104(4):1025-33. PubMed ID: 15126321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EphrinB2/EphB4 Signaling Regulates DPSCs to Induce Sprouting Angiogenesis of Endothelial Cells.
    Gong T; Xu J; Heng B; Qiu S; Yi B; Han Y; Lo ECM; Zhang C
    J Dent Res; 2019 Jul; 98(7):803-812. PubMed ID: 31017515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.
    Martiny-Baron G; Holzer P; Billy E; Schnell C; Brueggen J; Ferretti M; Schmiedeberg N; Wood JM; Furet P; Imbach P
    Angiogenesis; 2010 Sep; 13(3):259-67. PubMed ID: 20803239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble ephrin-B2 mediates apoptosis in retinal neovascularization and in endothelial cells.
    Davies MH; Zamora DO; Smith JR; Powers MR
    Microvasc Res; 2009 May; 77(3):382-6. PubMed ID: 19232363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.